Oxford Global Formulation and Drug Delivery Congress 2014 London

  • Conference Call
  • Oxford Global Con­fer­ences are proud to present the For­mu­la­tion & Drug Deliv­ery Con­gress, tak­ing place on 2 – 3 Octo­ber 2014 in Lon­don, United King­dom.

    New drug deliv­ery part­ner­ships, advances in for­mu­la­tion tech­nolo­gies and sig­nif­i­cant improve­ments in analy­sis capa­bil­i­ties are all cre­at­ing real oppor­tu­ni­ties in the prod­uct devel­op­ment field. This senior level con­gress brings together over 150 experts work­ing in for­mu­la­tion, deliv­ery and prod­uct devel­op­ment. Pre­sen­ta­tions will assess recent tech­no­log­i­cal inno­va­tions and dis­cuss their impact on prod­uct improve­ment and patient experience.

    Day One of the Con­gress will cover meth­ods to improve sta­bil­ity and bioavail­abil­ity. Speak­ers will dis­cuss the lat­est tech­nolo­gies being employed in crys­tal engi­neer­ing, par­ti­cle size reduc­tion and self emul­si­fi­ca­tion. Experts will also com­pare meth­ods for char­ac­ter­is­ing drug deliv­ery action and debate novel solu­tions for dif­fi­cult to deliver drugs.

    Day Two will look at the lat­est advances in process and prod­uct devel­op­ment. Pre­sen­ta­tions will cover con­tin­u­ous man­u­fac­tur­ing, clin­i­cal prod­uct test­ing and Qual­ity by Design ini­tia­tives. The pro­gramme will also cover ways of ensur­ing prod­uct qual­ity ear­lier in the pipeline, through pre-​formulation strat­egy and early stage inter­ven­tions. Day Two also fea­tures a ded­i­cated Bio­pharma stream, explor­ing the role of nan­otech­nolo­gies, HT method­olo­gies and early devel­opa­bil­ity screens in the for­mu­la­tion and deliv­ery of biologics.


    In keep­ing with Oxford Global’s highly suc­cess­ful life sci­ences series, an expert panel of 40 speak­ers will present a full con­fer­ence pro­gramme cov­er­ing the top­ics out­lined below.

    Day 1

    Opti­mis­ing Formulation

    • Opti­mis­ing for­mu­la­tion: improv­ing sta­bil­ity and bioavailability
    • De-​risking for­mu­la­tion strat­egy: IVIVC, pre­dic­tive mod­el­ling, early screen­ing, excip­i­ent com­pat­i­bil­ity testing
    • Advances in for­mu­la­tion test­ing: sta­bil­ity sim­u­la­tion test­ing, dis­so­lu­tion testing
    • Novel tech­nolo­gies: self-​emulsifying tech­nol­ogy, microformulations
    • Improv­ing sol­u­bil­ity: crys­tal engi­neer­ing, solid dis­per­sion, par­ti­cle size reduc­tion, hot melt extrusion

    Improv­ing Drug Delivery

    • Enhanc­ing drug effi­cacy from deliv­ery: par­enteral deliv­ery, long-​acting formulations
    • Char­ac­ter­is­ing drug deliv­ery action: imag­ing, par­ti­cle size analysis
    • Dif­fi­cult to deliver drugs: poorly sol­u­ble drugs, age appro­pri­ate delivery
    • The increas­ing role of nan­otech­nol­ogy in drug delivery
    • Drug deliv­ery case stud­ies: trans­der­mal, sublingual

    Day 2

    For­mu­la­tion and Drug Deliv­ery Strate­gies for Biopharma

    • Pre-​formulation activ­i­ties for bio­log­ics: pre­dict­ing pro­tein behav­iour, early screen­ing for developability
    • Opti­mis­ing bio­log­ics for­mu­la­tion: improv­ing qual­ity and stability
    • For­mu­lat­ing high con­cen­tra­tion and high strength proteins
    • For­mu­la­tion and deliv­ery chal­lenges for novel bio­log­i­cal drug formats
    • New tech­nol­ogy case stud­ies: nan­otech­nol­ogy, HT methodologies
    • Biosim­i­lar for­mu­la­tion and delivery

    Prod­uct Devel­op­ment Considerations

    • User-​focused prod­uct devel­op­ment: what do patients need from admin­is­tra­tion systems?
    • Imple­ment­ing Qual­ity by Design from pre-​formulation through to com­mer­cial manufacture
    • Man­ag­ing exter­nal stake­hold­ers: work­ing with CROs, CMOs and reg­u­la­tors to cre­ate the opti­mal deliv­ery system
    • Tech­nol­ogy and process trans­fer: from for­mu­la­tion research to suc­cess­ful prod­uct launch

    2014 Speakers

    • Sreed­hara Alavat­tam – Senior Scientist/​Senior Group Leader, Late Stage Phar­ma­ceu­ti­cal Devel­op­ment, Genentech
    • Anne Bechet – Direc­tor Project Man­age­ment, Prosensa
    • Steve Brown – Exec­u­tive Direc­tor, Phar­ma­ceu­ti­cal Tech­nol­ogy, Actavis
    • Paul Dalby – Pro­fes­sor of Bio­chem­i­cal Engi­neer­ing and Biotech­nol­ogy, UCL
    • Den­nis Douroumis – Direc­tor of Cen­tre for Inno­va­tion in Process Engi­neer­ing and Research (CIPER), Board Mem­ber of the Acad­emy of Phar­ma­ceu­ti­cal Sci­ences (APS), Reader in Phar­ma­ceu­ti­cal Sci­ences, Uni­ver­sity of Greenwich
    • David Haase – Senior Man­ager Device Devel­op­ment, Genentech
    • Sune Klint Ander­sen – Prin­ci­pal Sci­en­tist Dry­ing Processes, Novo Nordisk
    • Jayne Lawrence – Pro­fes­sor of Bio­phys­i­cal Phar­ma­ceu­tics, King’s College
    • Ulrik Lytt Rah­bek – Direc­tor, Head of ADME Depart­ment, Dia­betes Research, Novo Nordisk
    • Sachin Mit­tal – Direc­tor, Merck
    • Ric­cardo Pan­icucci – Global Head of Chem­i­cal & Phar­ma­ceu­ti­cal Pro­fil­ing (CPP), Novar­tis Insti­tutes for Bio­Med­ical Research, Inc.
    • Bernardo Perez-​Ramirez – Senior Sci­en­tific Direc­tor, Bio­For­mu­la­tions Devel­op­ment, Gen­zyme Corporation
    • Harpreet Sandhu – Prin­ci­pal Sci­en­tist, Merck
    • Yun Tang – Senior Man­ager, Ana­lyt­i­cal Oper­a­tions, Genentech
    • Thorsten Thor­mann – Senior Vice Pres­i­dent, LEO Pharma
    • Sal­vador Ven­tura – Full Pro­fes­sor, Pro­tein Fold­ing and Con­for­ma­tional Dis­eases Lab (PFCD), Uni­ver­si­tat Autònoma de Barcelona
    • Mark Wil­son – Direc­tor, Col­lab­o­ra­tion Man­age­ment, Europe, Plat­form Tech­nol­ogy and Sci­ence, GSK
    • Mark Yang – Direc­tor, Fill Fin­ish Devel­op­ment, Late Stage Process Devel­op­ment, Gen­zyme, A Sanofi Company
    • Matthew Yates – Direc­tor, Eli Lilly

    Sub­mit a poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists work­ing in indus­try and academia.

    We will require:

    Poster title, Abstract (200 words or less)
    Prin­ci­pal author, Organ­i­sa­tion
    Mail­ing address, Email, Tele­phone, Fax
    Addi­tional authors

    In order to secure your board space a fee of £250 will be required. The poster should be pre­sented as A0 (841mm x 1189mm) por­trait size.

    To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able, so please reg­is­ter soon.

    Who will attend

    The For­mu­la­tion & Drug Deliv­ery Con­gress is an exclu­sive event designed for senior level atten­dees from lead­ing phar­ma­ceu­ti­cal, bio­phar­ma­ceu­ti­cal, biotech­nol­ogy, diag­nos­tics, CRO and solu­tion provider com­pa­nies, along with highly esteemed mem­bers of aca­d­e­mic and gov­ern­ment institutions.

    Del­e­gates typ­i­cally include VPs, Direc­tors and Global Heads of:

    • Admin­is­tra­tion systems
    • Bio­man­u­fac­tur­ing
    • Bio­pro­cess­ing
    • CMC
    • Deliv­ery devices
    • Drug deliv­ery
    • For­mu­la­tion for biologics
    • For­mu­la­tion technology
    • Life­cy­cle management
    • Man­u­fac­tur­ing
    • Nan­otech­nol­ogy
    • Pre-​formulation strategies
    • Process improve­ment
    • Prod­uct characterisation
    • Prod­uct development
    • Prod­uct formulation
    • Prod­uct testing
    • Qual­ity By Design
    • Sta­bil­ity testing
    • Tech­nol­ogy development
    starting: ending: 03.10.2014 Location: , Category:


    Conference START 03.10.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.